Transfusion-associated Graft-versus-Host Disease (TA-GVHD) is a notoriously deadly but thankfully rare transfusion complication. Blood banks have used irradiation of cellular blood products for decades to prevent TA-GVHD, but clinicians and laboratorians still sometimes misunderstand what irradiation does and does not do. Dr. Chris Tormey from Yale details the past, present, and future of blood product irradiation in this practical and timely interview.
Continuing education for this episode has EXPIRED. See BBGuy.org/CE or AABB.org/BBGuy for current CE-eligible episodes.
